+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Migraine Drug"

Pain Management Devices Market 2024-2028 - Product Thumbnail Image

Pain Management Devices Market 2024-2028

  • Report
  • July 2024
  • 172 Pages
  • Global
From
From
From
From
From
From
Migraine Drugs Market 2024-2028 - Product Thumbnail Image

Migraine Drugs Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
Migraine: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Migraine: 68-Market Analysis and Sales Forecast

  • Report
  • August 2024
  • 18 Pages
  • Global
From
Migraine: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Migraine: Seven-Market Drug Forecast and Market Analysis

  • Report
  • August 2024
  • 121 Pages
  • Global
From
Migraine: Epidemiology Forecast to 2033 - Product Thumbnail Image

Migraine: Epidemiology Forecast to 2033

  • Report
  • July 2024
  • 48 Pages
  • Global
From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
Loading Indicator

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists. Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more